| Product Code: ETC6744421 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Haemophilia Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Haemophilia Market Revenues & Volume, 2021 & 2031F |
3.3 China Haemophilia Market - Industry Life Cycle |
3.4 China Haemophilia Market - Porter's Five Forces |
3.5 China Haemophilia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 China Haemophilia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 China Haemophilia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 China Haemophilia Market Revenues & Volume Share, By Patient, 2021 & 2031F |
3.9 China Haemophilia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 China Haemophilia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 China Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Haemophilia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of haemophilia in China |
4.2.2 Growing government investments in healthcare infrastructure and treatment options for haemophilia patients |
4.2.3 Rising prevalence of haemophilia due to factors such as aging population and lifestyle changes |
4.3 Market Restraints |
4.3.1 Limited access to advanced treatment options and therapies in certain regions of China |
4.3.2 High cost associated with haemophilia treatments and therapies, leading to affordability issues for some patients |
4.3.3 Lack of skilled healthcare professionals specialized in haemophilia management |
5 China Haemophilia Market Trends |
6 China Haemophilia Market, By Types |
6.1 China Haemophilia Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 China Haemophilia Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 China Haemophilia Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 China Haemophilia Market Revenues & Volume, By Desmopressin, 2021- 2031F |
6.1.5 China Haemophilia Market Revenues & Volume, By Emicizumab, 2021- 2031F |
6.1.6 China Haemophilia Market Revenues & Volume, By Anti-fibrinolytics, 2021- 2031F |
6.1.7 China Haemophilia Market Revenues & Volume, By ITI Therapy, 2021- 2031F |
6.1.8 China Haemophilia Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.9 China Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 China Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Haemophilia Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 China Haemophilia Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 China Haemophilia Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 China Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Haemophilia Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 China Haemophilia Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.3.3 China Haemophilia Market Revenues & Volume, By Genetic Tests, 2021- 2031F |
6.3.4 China Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Haemophilia Market, By Patient |
6.4.1 Overview and Analysis |
6.4.2 China Haemophilia Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4.3 China Haemophilia Market Revenues & Volume, By Adult, 2021- 2031F |
6.5 China Haemophilia Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 China Haemophilia Market Revenues & Volume, By Haemophilia A, 2021- 2031F |
6.5.3 China Haemophilia Market Revenues & Volume, By Haemophilia B, 2021- 2031F |
6.5.4 China Haemophilia Market Revenues & Volume, By Haemophilia C, 2021- 2031F |
6.5.5 China Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Haemophilia Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 China Haemophilia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 China Haemophilia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 China Haemophilia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 China Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7 China Haemophilia Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 China Haemophilia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 China Haemophilia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 China Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 China Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
7 China Haemophilia Market Import-Export Trade Statistics |
7.1 China Haemophilia Market Export to Major Countries |
7.2 China Haemophilia Market Imports from Major Countries |
8 China Haemophilia Market Key Performance Indicators |
8.1 Number of haemophilia patients diagnosed and under treatment in China |
8.2 Adoption rate of new and advanced treatment options for haemophilia |
8.3 Rate of adherence to treatment plans among haemophilia patients |
9 China Haemophilia Market - Opportunity Assessment |
9.1 China Haemophilia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 China Haemophilia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 China Haemophilia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 China Haemophilia Market Opportunity Assessment, By Patient, 2021 & 2031F |
9.5 China Haemophilia Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 China Haemophilia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 China Haemophilia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Haemophilia Market - Competitive Landscape |
10.1 China Haemophilia Market Revenue Share, By Companies, 2024 |
10.2 China Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here